OPIOID CRAVING
Clinical trials for OPIOID CRAVING explained in plain language.
Never miss a new study
Get alerted when new OPIOID CRAVING trials appear
Sign up with your email to follow new studies for OPIOID CRAVING, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could buspirone and lofexidine take the edge off opioid withdrawal?
Symptom relief Recruiting nowThis Phase 2 trial tests whether adding buspirone (an anxiety medication) to lofexidine (a withdrawal drug) can reduce opioid withdrawal symptoms and cravings during detox. About 100 adults with opioid use disorder will stay in a residential setting for 10–12 days, undergo a step…
Matched conditions: OPIOID CRAVING
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New study aims to improve opioid craving measurement
Knowledge-focused Recruiting nowThis study aims to create a better tool for measuring opioid cravings in people being treated for opioid use disorder. Researchers will show participants opioid-related images and objects, then interview them about their feelings and thoughts. The goal is to improve how cravings …
Matched conditions: OPIOID CRAVING
Phase: NA • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Scientists study why opioid withdrawal hits some harder than others
Knowledge-focused Recruiting nowThis study looks at how opioid withdrawal symptoms vary from person to person. Sixty adults with opioid use disorder will go through a medically supervised taper using hydromorphone and lofexidine. Researchers will measure withdrawal severity during the taper and after a naloxone…
Matched conditions: OPIOID CRAVING
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:36 UTC